Publications by authors named "Deborah Rudin"

N,N-dimethyltryptamine (DMT) is a serotonergic psychedelic that is known for its short-lasting effects when administered intravenously. Several studies have investigated the administration of intravenous boluses or combinations of a bolus and a subsequent continuous infusion. However, data on dose-dependent acute effects and pharmacokinetics of continuous DMT infusions are lacking.

View Article and Find Full Text PDF

The antidepressant-like activity of two psychoplastogens, ibogainalog (IBG) and ibogaminalog (DM506), was studied in naïve mice using the forced swim test (FST) and tail suspension test (TST). The behavioral results showed that a single administration of 25 mg/kg DM506 or 10 mg/kg IBG induced antidepressant-like activity in naïve mice in a volinanserin-sensitive manner that persisted for 72 h. Similar results were observed using the chronic immobilization stress (CIS) test, in which depression symptoms were reduced for 48 h.

View Article and Find Full Text PDF
Article Synopsis
  • - Influenza B viruses, while often overlooked, pose a significant global health threat and exhibit differences in vaccine response compared to Influenza A viruses.
  • - The literature review assesses immune responses from phase 3 studies of seasonal influenza vaccines, revealing that immunity to B strains can be less robust and variable due to factors like prior exposure, assay limitations, and strain mismatches.
  • - The findings suggest a need for further research to better understand these immune response discrepancies and to improve vaccine effectiveness against Influenza B, ultimately aiming to reduce the global disease burden.
View Article and Find Full Text PDF
Article Synopsis
  • MDMA, known for boosting mood and empathy, was compared with its enantiomers S-MDMA and R-MDMA in a controlled study to explore their effects on participants' experiences of stimulation and psychedelia.
  • S-MDMA (125 mg) produced stronger subjective effects and increased blood pressure compared to both R-MDMA doses and regular MDMA, while R-MDMA did not show notable psychedelic effects as expected.
  • Pharmacokinetic analysis revealed that S-MDMA has a shorter elimination half-life (4.1 hours) and results in higher plasma levels of prolactin, cortisol, and oxytocin compared to R-MDMA, which has a longer half-life (12-14 hours) and weaker stimulant
View Article and Find Full Text PDF
Article Synopsis
  • The serotonin 2A (5-HT2A) receptor plays a key role in the effects of classical psychedelics and is a target for new drug development.
  • A PET study was conducted to examine how ketanserin, a 5-HT2A receptor antagonist, affects receptor occupancy in healthy participants after different doses.
  • The findings indicate that ketanserin increases 5-HT2A receptor occupancy in a dose-dependent manner, providing insights into its potential therapeutic applications and usefulness in studying brain function.
View Article and Find Full Text PDF

The aim of this study was to determine the anti-hypersensitivity activity of novel non-hallucinogenic compounds derived from iboga alkaloids (i.e., ibogalogs), including tabernanthalog (TBG), ibogainalog (IBG), and ibogaminalog (DM506), using mouse models of neuropathic (Chronic Constriction Injury; CCI) and visceral pain (dextrane sulfate sodium; DSS).

View Article and Find Full Text PDF
Article Synopsis
  • Psilocybin is quickly converted to psilocin, which produces psychedelic effects by targeting the 5-HT receptor, and its metabolism involves converting psilocin to other compounds like 4-HIAA and 4-HTP.
  • The study analyzed metabolic processes using human liver microsomes and various enzymes, revealing that male C57BL/6J mice and human samples showed different metabolic rates and pathways for psilocin.
  • Key enzymes such as MAO-A, CYP2D6, and CYP3A4 play roles in psilocin metabolism, with the identification of new metabolites like norpsilocin and oxidized psilocin, which could inform future research on drug interactions and ps
View Article and Find Full Text PDF
Article Synopsis
  • * Between 2011 and 2020, research showed that antigenic drift led to vaccine mismatches in four seasons, while egg-adaptive mutations contributed to mismatches in six seasons, indicating a consistent issue with current vaccine methods.
  • * mRNA vaccine technology, which has shown success against COVID-19, is being examined for seasonal influenza as a potential solution for strain mismatch, with innovative multi-component strategies being developed to enhance vaccine effectiveness.
View Article and Find Full Text PDF

3,4-Methylenedioxymethamphetamine (MDMA) is an entactogen with therapeutic potential. The two enantiomers of MDMA differ regarding their pharmacokinetics and pharmacodynamics but the chiral pharmacology of MDMA needs further study in clinical trials. Here, an achiral and an enantioselective high performance liquid chromatography-tandem mass spectrometry method for the quantification of MDMA and its psychoactive phase I metabolite 3,4-methylenedioxyamphetamine (MDA) in human plasma were developed and validated.

View Article and Find Full Text PDF

Understanding pharmacokinetics (PK) in children is a prerequisite to determine optimal pediatric dosing. As plasma sampling in children is challenging, alternative PK sampling strategies are needed. In this case study we evaluated the suitability of saliva as alternative PK matrix to simplify studies in infants, investigating metamizole, an analgesic used off-label in infants.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigated the effects of DM506, a non-hallucinogenic compound from ibogamine, on anxiety and sedation in mice using various behavioral tests.
  • Findings revealed that a dose of 15 mg/kg DM506 provided both acute and lasting anxiolytic effects, while higher doses (40 mg/kg) produced sedative effects that could be blocked by a specific 5-HT receptor antagonist.
  • Electroencephalography showed that DM506 altered brain activity from alertness to deep sleep, demonstrating its potential as a safe anxiolytic and sedative without the hallucinogenic side effects typical of other compounds.
View Article and Find Full Text PDF

N,N-dimethyltryptamine (DMT) is distinct among classic serotonergic psychedelics because of its short-lasting effects when administered intravenously. Despite growing interest in the experimental and therapeutic use of intravenous DMT, data are lacking on its clinical pharmacology. We conducted a double-blind, randomized, placebo-controlled crossover trial in 27 healthy participants to test different intravenous DMT administration regimens: placebo, low infusion (0.

View Article and Find Full Text PDF

Introduction: Classic psychedelics have been shown to exert therapeutic potential for the treatment of various psychiatric disorders, neuropsychiatric diseases, and neuronal damage. Besides their psychopharmacological activity, psychedelics have been reported to modulate immune functions. There has thus far been a sparse exploration of the direct immune-modulating effect of psychedelics on human immune cells .

View Article and Find Full Text PDF

The plasmalemmal norepinephrine transporter (NET) regulates cardiovascular sympathetic activity by clearing extracellular norepinephrine in the synaptic cleft. Here, we investigate the subunit stoichiometry and function of NET using single-molecule fluorescence microscopy and flux assays. In particular, we show the effect of phosphatidylinositol 4,5-bisphosphate (PIP) on NET oligomerization and efflux.

View Article and Find Full Text PDF

We estimated the frequency of non-specific influenza-associated clinical endpoints to inform the feasibility of pragmatic randomized controlled trials (RCT) assessing relative vaccine effectiveness (rVE). Hospitalization rates of respiratory, cardiovascular and diabetic events were estimated from Denmark and England's electronic databases and stratified by age, comorbidity and influenza vaccination status. We included a seasonal average of 4.

View Article and Find Full Text PDF

Background: Recombinant influenza vaccine (RIV) has been in use in US adults since 2013. This study evaluated the safety of quadrivalent recombinant influenza vaccine (RIV4, Flublok® Quadrivalent, Sanofi Pasteur) compared with standard-dose quadrivalent inactivated influenza vaccine (SD-IIV4) in self-identified Chinese adults at Kaiser Permanente Northern California (KPNC).

Methods: This study evaluated adults aged 18-64 years within KPNC during the 2018-2019 influenza season who self-identified as Chinese (NCT03694392).

View Article and Find Full Text PDF

The influenza vaccine field has been constantly evolving to improve the speed, scalability, and flexibility of manufacturing, and to improve the breadth and longevity of the protective immune response across age groups, giving rise to an array of next generation vaccines in development. Among these, the recombinant influenza vaccine tetravalent (RIV4), using a baculovirus expression vector system to express recombinant haemagglutinin (rHA) in insect cells, is the only one to have reached the market and has been studied extensively. We describe how the unique structural features of rHA in RIV4 improve protective immune responses compared to conventional influenza vaccines made from propagated influenza virus.

View Article and Find Full Text PDF

Derivatives of (2-aminopropyl)indole (API) and (2-aminopropyl)benzofuran (APB) are new psychoactive substances which produce stimulant effects in vivo. (2-Aminopropyl)benzo[β]thiophene (APBT) is a novel sulfur-based analog of API and APB that has not been pharmacologically characterized. In the current study, we assessed the pharmacological effects of six APBT positional isomers in vitro, and three of these isomers (3-APBT, 5-APBT, and 6-APBT) were subjected to further investigations in vivo.

View Article and Find Full Text PDF

The utilization of fluorescent ligands to study the monoamine transporters (MATs) has increased our knowledge of their function and distribution in live cell systems. In this study, we extend SAR for nisoxetine and talopram as parent compounds, to identify high affinity rhodamine-labeled fluorescent probes for the norepinephrine transporter (NET). Nisoxetine-based fluorescent probe demonstrated high binding affinity ( = 43 nM) for NET and an overall selectivity compared to the other transporters for dopamine (DAT; = 1540 nM) and serotonin (SERT; = 785 nM) in competitive radioligand binding assays.

View Article and Find Full Text PDF

New psychoactive stimulants and psychedelics continue to play an important role on the illicit new psychoactive substance (NPS) market. Designer stimulants and psychedelics both affect monoaminergic systems, although by different mechanisms. Stimulant NPS primarily interact with monoamine transporters, either as inhibitors or as substrates.

View Article and Find Full Text PDF

Organic cation transporters 1-3 (OCT1-3, SLC22A1-3) and the plasma membrane monoamine transporter (PMAT, SLC29A4) play a major role in maintaining monoaminergic equilibrium in the central nervous system. With many psychoactive substances interacting with OCT1-3 and PMAT, a growing literature focuses on characterizing their properties via in vitro and in vivo studies. In vitro studies mainly aim at characterizing compounds as inhibitors or substrates of murine, rat, and human isoforms.

View Article and Find Full Text PDF

While classical cathinones, such as methcathinone, have been shown to be monoamine releasing agents at human monoamine transporters, the subgroup of α-pyrrolidinophenones has thus far solely been characterized as monoamine transporter reuptake inhibitors. Herein, we report data from previously undescribed α-pyrrolidinopropiophenone (α-PPP) derivatives and compare them with the pharmacologically well-researched α-PVP (α-pyrrolidinovalerophenone). Radiotracer-based in vitro uptake inhibition assays in HEK293 cells show that the investigated α-PPP derivatives inhibit the human high-affinity transporters of dopamine (hDAT) and norepinephrine (hNET) in the low micromolar range, with α-PVP being ten times more potent.

View Article and Find Full Text PDF
Article Synopsis
  • Agranulocytosis is a serious but rare side effect linked to metamizole, an analgesic popular in countries like Switzerland and Germany, and its underlying causes are not yet understood.
  • Researchers conducted a multi-center study to find genetic factors that might make people susceptible to this adverse reaction, analyzing data from various European populations without finding strong associations.
  • However, they did discover two candidate genetic loci on chromosome 9 that show potential relevance to the condition, which could guide future studies exploring the mechanisms behind agranulocytosis related to metamizole.
View Article and Find Full Text PDF
Article Synopsis
  • Agranulocytosis is a serious condition linked to taking metamizole (dipyrone) and involves a harmful decrease in a type of white blood cell, with potential genetic factors contributing to vulnerability.
  • This study aimed to find any link between genetic variants in HLA genes and the risk of developing metamizole-induced agranulocytosis (MIA) among European patients, focusing on a Swiss cohort.
  • Although eight candidate alleles were identified, only one showed a significant connection to MIA in the Swiss group, and no consistent associations were found across cohorts from Switzerland, Germany, and Spain.
View Article and Find Full Text PDF
Article Synopsis
  • Metamizole, an analgesic, becomes toxic when metabolized to N-methyl-aminoantipyrine (MAA), especially in the presence of heme iron, which affects granulocyte precursor cells.
  • In experiments with HL60 cells, the combination of MAA and hemin caused greater ATP depletion than hemin alone, indicating that ATP loss is a key mechanism of MAA/hemin toxicity.
  • MAA itself is not toxic at low concentrations but enhances the negative effects of hemin on cellular energy processes, particularly glycolysis, by generating reactive metabolites and reducing pyruvate kinase protein levels.
View Article and Find Full Text PDF

A PHP Error was encountered

Severity: Notice

Message: fwrite(): Write of 34 bytes failed with errno=28 No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 272

Backtrace:

A PHP Error was encountered

Severity: Warning

Message: session_write_close(): Failed to write session data using user defined save handler. (session.save_path: /var/lib/php/sessions)

Filename: Unknown

Line Number: 0

Backtrace: